JAN 22, 2021 8:24 AM PST

Breast Cancer's Nasty Nine Revealed

WRITTEN BY: Tara Fernandez

Calculating an individual’s risk of developing breast cancer isn’t easy. There’s a complex interplay between genetic and environmental factors—family history, getting older, and drinking alcohol are among a long list of risk factors. 

Given that risk estimation isn’t always black and white, how do individuals know if they need to seek preemptive clinical interventions? Irish cancer experts may now have the answer to this by teasing out specific genetic markers that are strong predictors of breast cancer development. The study was published recently in the New England Journal of Medicine.

Their genomic study of over 113,000 breast cancer patients and healthy controls has revealed a panel of nine specific gene variants that influence cancer susceptibility: ATM, BRCA1, BRCA2, CHEK2, PALB2, BARD1, RAD51C, RAD51D, and TP53. These nine genes could be used in health screens to help physicians identify which of their patients have elevated chances of developing malignancies.

Until now, BRCA gene mutations have been among the most talked-about genetic risk factors in relation to breast and ovarian cancers. In the United States, around 1 in every 500 women has a mutation in either the BRCA1 or BRCA2 gene. Of these, 50 out of every 100 women with a mutation will get breast cancer before turning 70—about a 7 times higher chance than those without the mutation.

Identifying more “risk” genes, especially those with strong associations to cancer development, helps make the susceptibility calculator more precise and accurate.

Professor Michael Kerin, who led the research efforts, said: "With this study we can identify the members within families who have abnormal genes that puts them at a higher risk of getting breast cancer, and they can avail of strategies such as early screening and risk reduction surgery, in order to improve their life expectancy."

Around the world, breast cancer is the most commonly occurring cancer in women with over 2 million new cases in 2018. While our genetic inheritance is beyond our control, this work highlights how women can leverage this genetic information to gain back some control over their health outcomes in the future.

 

Sources: National University of Ireland Galway, NEJM.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 27, 2020
Clinical & Molecular DX
A Super Sensitive Alzheimer's Test Powered by Nanozymes
OCT 27, 2020
A Super Sensitive Alzheimer's Test Powered by Nanozymes
  Simple tasks are now uphill struggles, social situations aren’t fun, and the car keys are missing again. By ...
NOV 10, 2020
Clinical & Molecular DX
No More False-Negatives: An Ultrasensitive COVID Test
NOV 10, 2020
No More False-Negatives: An Ultrasensitive COVID Test
A team of researchers has improved upon the current diagnostic methodology for COVID-19, making it significantly more ac ...
NOV 14, 2020
Cannabis Sciences
Half of CBD Users Test Positive for THC in Urine Tests
NOV 14, 2020
Half of CBD Users Test Positive for THC in Urine Tests
Despite the growing popularity of cannabidiol (CBD) products, there has been little research directly assessing whether ...
DEC 29, 2020
Clinical & Molecular DX
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
DEC 29, 2020
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
The statistics are a real eye-opener: in the United States, one person dies every 36 seconds from cardiovascular disease ...
JAN 12, 2021
Cell & Molecular Biology
Hyperactive Mitochondria Can Fuel Brain Tumors
JAN 12, 2021
Hyperactive Mitochondria Can Fuel Brain Tumors
The most common and deadly form of brain cancer is known as glioblastoma; the median survival time for patients is only ...
FEB 02, 2021
Immunology
Pumping the Brakes on Stomach Cancer Progression
FEB 02, 2021
Pumping the Brakes on Stomach Cancer Progression
By the time stomach cancer is diagnosed, it’s often bad news for patients. The disease often presents with relativ ...
Loading Comments...